HCA Healthcare, Inc. (HCA)
NYSE: HCA · Real-Time Price · USD
451.09
+6.08 (1.37%)
At close: Oct 9, 2026, 4:00 PM EDT
445.04
-6.05 (-1.34%)
After-hours: Oct 9, 2026, 7:42 PM EDT
HCA Healthcare Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 97,662 | 106,535 | 76,027 | 72,450 | 67,841 | 79,908 | |
Market Cap Growth | -2.09% | 40.13% | 4.94% | 6.79% | -15.10% | 43.59% |
Enterprise Value | 148,084 | 154,969 | 120,901 | 115,412 | 108,783 | 115,349 |
Last Close Price | 451.09 | 464.38 | 296.33 | 265.17 | 232.94 | 246.87 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 15.10 | 15.70 | 13.20 | 13.82 | 12.02 | 11.49 |
Forward PE | 14.74 | 15.90 | 12.60 | 14.25 | 13.45 | 14.11 |
PS Ratio | 1.25 | 1.41 | 1.08 | 1.12 | 1.13 | 1.36 |
PB Ratio | - | -38.45 | 136.99 | 68.35 | -929.32 | 53.67 |
P/FCF Ratio | 16.29 | 13.85 | 13.48 | 15.46 | 16.44 | 14.85 |
P/OCF Ratio | 8.78 | 8.43 | 7.23 | 7.68 | 7.96 | 8.92 |
PEG Ratio | 1.56 | 1.22 | 1.01 | 1.67 | 1.78 | 1.04 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 1.90 | 2.05 | 1.71 | 1.78 | 1.81 | 1.96 |
EV/EBITDA Ratio | 9.40 | 10.01 | 8.72 | 9.09 | 9.05 | 9.21 |
EV/EBIT Ratio | 12.27 | 12.95 | 11.46 | 11.99 | 12.02 | 11.92 |
EV/FCF Ratio | 24.69 | 20.15 | 21.44 | 24.62 | 26.36 | 21.43 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | -16.07 | -17.57 | 81.51 | 39.49 | -550.68 | 24.67 |
Debt / EBITDA Ratio | 3.07 | 2.95 | 3.03 | 3.06 | 3.09 | 2.72 |
Debt / FCF Ratio | 8.60 | 6.33 | 8.02 | 8.93 | 9.74 | 6.83 |
Net Debt / Equity Ratio | -15.71 | -17.16 | 77.87 | 38.53 | -536.99 | 23.63 |
Net Debt / EBITDA Ratio | 3.20 | 3.07 | 3.12 | 3.22 | 3.26 | 2.81 |
Net Debt / FCF Ratio | 8.41 | 6.18 | 7.66 | 8.71 | 9.50 | 6.54 |
Asset Turnover | 1.27 | 1.26 | 1.22 | 1.20 | 1.17 | 1.20 |
Inventory Turnover | 25.94 | 26.09 | 22.31 | 19.27 | 18.28 | 18.08 |
Quick Ratio | 0.78 | 0.74 | 0.85 | 0.87 | 1.00 | 1.01 |
Current Ratio | 0.99 | 0.97 | 1.08 | 1.18 | 1.38 | 1.41 |
Return on Equity (ROE) | - | - | 824.40% | 1234.24% | 965.25% | 352.48% |
Return on Assets (ROA) | 12.29% | 12.44% | 11.39% | 11.07% | 10.97% | 12.31% |
Return on Invested Capital (ROIC) | 21.80% | 21.49% | 19.23% | 18.02% | 18.21% | 21.48% |
Return on Capital Employed (ROCE) | 26.30% | 27.00% | 23.80% | 22.10% | 21.30% | 23.50% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 7.00% | 6.37% | 7.58% | 7.23% | 8.32% | 8.71% |
FCF Yield | 6.14% | 7.22% | 7.42% | 6.47% | 6.08% | 6.73% |
Dividend Yield | 0.69% | 0.62% | 0.89% | 0.91% | 0.96% | 0.78% |
Payout Ratio | 10.44% | 10.01% | 11.98% | 12.61% | 11.57% | 8.97% |
Buyback Yield / Dilution | 8.97% | 8.52% | 5.28% | 6.19% | 10.37% | 4.32% |
Total Shareholder Return | 9.66% | 9.14% | 6.17% | 7.10% | 11.33% | 5.10% |